The U.S. cancer contrast media market size was valued at USD 708.07 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2030. The increasing number of cancer cases in the U.S. has significantly fueled the demand for cancer diagnostic and imaging devices, which drives the market growth. The diagnostic imaging techniques such as CT scans, MRI scans and X-rays use contrast media in enhancing the visibility of specific body structures.
Read More »January 10, 2024
The U.S. contrast media injectors market size was valued at USD 401.8 million in 2023 and is expected to grow at a CAGR of 6.5% from 2024 to 2030. The market growth is attributed to the increasing prevalence of chronic disorders, technological advancements, along with growing demand for minimally invasive surgical procedures.
Read More »March 18, 2024
The U.S. gadolinium-based contrast media market size was valued at USD 527.9 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2020 to 2027. This growth can be attributed to the increasing prevalence of long term chronic diseases and technological advancements. The market is majorly driven by the growing prevalence of complex morbidities and label expansion such as mergers and acquisitions by key players.
Read More »August 21, 2020
The U.S. contrast media market size was valued at USD 2.43 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.1% from 2023 to 2030. The increasing burden of chronic diseases is creating a demand for diagnostic imaging procedures, which, in turn, is driving the market. Imaging tests, such as MRI, have become an integral part of the diagnosis for most diseases, and large-scale penetration of imaging technology in healthcare has increased the demand for contrast media in the U.S
Read More »November 21, 2023
The global contrast media market size was estimated at USD 6.28 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.98% from 2024 to 2030. The growing prevalence of complex comorbidities and long-term diseases has led to an increase in diagnostic imaging tests including ultrasound, X-rays, and advanced imaging technology such as MRI & CT scans.
Read More »November 16, 2023
The global contrast media injectors market size was valued at USD 1.19 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030. The growth of the contrast media injectors market is attributed to the rising prevalence of chronic disorders, technological advancements, along with globally increasing demand for minimally invasive surgical procedures.
Read More »May 24, 2023
The global high pressure contrast media injectors market size was valued at USD 119.6 million in 2020 and is anticipated to expand at a compound annual growth rate (CAGR) of 12.1% from 2021 to 2028. The increasing incidence of chronic conditions such as cardiovascular, neurovascular, and cancer, is likely to boost the demand for high pressure contrast media injectors in the coming years.
Read More »September 8, 2021
The global angiography equipment market size was valued at USD 10.05 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030. The increasing scope of applications and technological innovations are expected to be the key growth-driving factors for the market. Investments in the healthcare sector, the increasing geriatric population, and the rising prevalence of Cardiovascular Diseases (CVDs) are other prominent factors responsible for market growth
Read More »December 5, 2023
The global MRI contrast media agents market size was valued at USD 1.98 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.15% from 2023 to 2030. MRI contrast media agents are widely used to identify the presence of tumors, aneurysms, and other tissue abnormalities. This market holds a high growth potential due to the enormous research and development in this space to develop contrast media agents with reduced ill effects, minimized the occurrence of adverse reactions, minimal dosing, and improve imaging efficacy.
Read More »March 1, 2023